Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma

Slow and progressive loss of retinal ganglion cells (RGCs) is the main characteristic of glaucoma, the second leading cause of blindness worldwide. Previous studies have shown that impaired mitochondrial dynamics could facilitate retinal neurodegeneration. Mitochondrial dynamics are regulated direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonner, Henrik, Hunn, Selina, Auler, Nadine, Schmelter, Carsten, Pfeiffer, Norbert, Grus, Franz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654827/
https://www.ncbi.nlm.nih.gov/pubmed/36362420
http://dx.doi.org/10.3390/ijms232113618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654827/
https://www.ncbi.nlm.nih.gov/pubmed/36362420
http://dx.doi.org/10.3390/ijms232113618

Ejemplares similares